Marinus Pharmaceuticals
MRNS · NASDAQ
Price unavailable right now.
No price history for this range.
Who owns MRNS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 53.4% of MRNS’s shares.
- Panacea Venture10.0%
- Beryl Capital Management, LLC7.7%
- Morgan Stanley & Co. LLC6.0%
- Oddo BHF Asset Management S.A.S4.9%
- Next 6 largest institutions24.9%
- All other shareholders46.6%
| Holder | Shares | % of shares |
|---|---|---|
| Panacea Venture | 5.50M | 9.96% |
| Beryl Capital Management, LLC | 4.23M | 7.66% |
| Morgan Stanley & Co. LLC | 3.30M | 5.97% |
| Oddo BHF Asset Management S.A.S | 2.70M | 4.89% |
| Bain Capital Life Sciences Investors, LLC | 2.69M | 4.88% |
| abrdn Inc. | 2.66M | 4.81% |
| The Vanguard Group, Inc. | 2.60M | 4.70% |
| Woodline Partners LP | 2.34M | 4.23% |
| GSA Capital Partners LLP | 1.84M | 3.33% |
| Tang Capital Management, LLC | 1.64M | 2.97% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Franklin Templeton Investment Funds -Biotechnology Discovery | 2.99M | 5.41% |
| Vanguard Total Stock Market Index Fund | 1.73M | 3.13% |
| Franklin Biotechnology Discovery Fund | 1.20M | 2.17% |
| Vanguard Extended Market Index Fund | 811.00K | 1.47% |
| abrdn Healthcare Investors | 750.29K | 1.36% |
Short interest
Settled Jan 31, 2025
- Shares short
- 2.18M
- Days to cover
- 1.44
- % of shares outstanding
- 3.95%
- Average daily volume
- 1.52M
- Change since last report
- −6.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.